These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19332908)

  • 21. Changing trends in the antibiograms of Salmonella isolates at a tertiary care hospital in Hyderabad.
    Lakshmi V; Ashok R; Susmita J; Shailaja VV
    Indian J Med Microbiol; 2006 Jan; 24(1):45-8. PubMed ID: 16505555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antimicrobial resistance and molecular subtypes of
    Kong XX; Dong C; Ji H; Wang Y; Bao CC; Huo X; Qian HM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Nov; 38(11):1546-1550. PubMed ID: 29141347
    [No Abstract]   [Full Text] [Related]  

  • 23. A multiplex single nucleotide polymorphism typing assay for detecting mutations that result in decreased fluoroquinolone susceptibility in Salmonella enterica serovars Typhi and Paratyphi A.
    Song Y; Roumagnac P; Weill FX; Wain J; Dolecek C; Mazzoni CJ; Holt KE; Achtman M
    J Antimicrob Chemother; 2010 Aug; 65(8):1631-41. PubMed ID: 20511368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Characteristics of drug resistance and molecular type of Salmonella typhi and Salmonella paratyphi isolated in Henan province, 2009-2011].
    Zhao J; Xie Z; Mu Y; Su J; Xia S; Huang X; Xu B
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jan; 37(1):111-4. PubMed ID: 26822656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Antimicrobial Susceptibility Profile in Salmonella Typhi and Salmonella Paratyphi A: Presenting the Current Scenario in India and Strategy for Future Management.
    Veeraraghavan B; Pragasam AK; Ray P; Kapil A; Nagaraj S; Perumal SPB; Saigal K; Thomas M; Gupta M; Rongsen-Chandola T; Jinka DR; Shastri J; Alexander AP; Koshy RM; De A; Singh A; Evelyn Ebenezer S; Dutta S; Bavdekar A; More D; Sanghavi S; Nayakanti RR; Jacob JJ; Amladi A; Anandan S; Abirami BS; Bakthavatchalam YD; Sethuvel DPM; John J; Kang G
    J Infect Dis; 2021 Nov; 224(Supple 5):S502-S516. PubMed ID: 35238369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of Salmonella enterica serovars Typhi and Paratyphi.
    Day MR; Doumith M; Do Nascimento V; Nair S; Ashton PM; Jenkins C; Dallman TJ; Stevens FJ; Freedman J; Hopkins KL; Woodford N; De Pinna EM; Godbole G
    J Antimicrob Chemother; 2018 Feb; 73(2):365-372. PubMed ID: 29216342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High level ciprofloxacin resistance in Salmonella enterica isolated from blood.
    Raveendran R; Wattal C; Sharma A; Oberoi JK; Prasad KJ; Datta S
    Indian J Med Microbiol; 2008; 26(1):50-3. PubMed ID: 18227598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of mutations in the gyrA gene in fluoroquinolone resistance Salmonella enterica serotypes typhi and paratyphi A isolated from the Infectious Diseases Hospital, Kuwait.
    Dimitrov T; Dashti AA; Albaksami O; Jadaon MM
    J Clin Pathol; 2010 Jan; 63(1):83-7. PubMed ID: 19889623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic resistance of Salmonella enterica serovar Paratyphi A in India: emerging and reemerging problem.
    Mandal S; Mandal MD; Pal NK
    J Postgrad Med; 2006; 52(3):163-6. PubMed ID: 16855314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multidrug-resistant and extended-spectrum beta-lactamase (ESBL)-producing Salmonella enterica (serotypes Typhi and Paratyphi A) from blood isolates in Nepal: surveillance of resistance and a search for newer alternatives.
    Pokharel BM; Koirala J; Dahal RK; Mishra SK; Khadga PK; Tuladhar NR
    Int J Infect Dis; 2006 Nov; 10(6):434-8. PubMed ID: 16978898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced susceptibility to ciprofloxacin and gyra gene mutation in North Indian strains of Salmonella enterica serotype Typhi and serotype Paratyphi A.
    Renuka K; Kapil A; Kabra SK; Wig N; Das BK; Prasad VV; Chaudhry R; Seth P
    Microb Drug Resist; 2004; 10(2):146-53. PubMed ID: 15256030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of azithromycin in Salmonella isolates from Pakistan.
    Butt F; Sultan F
    J Infect Dev Ctries; 2011 May; 5(5):391-5. PubMed ID: 21628817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic resistance among Salmonella enterica serovars Typhi and Paratyphi A in Pakistan (2001-2006).
    Hasan R; Zafar A; Abbas Z; Mahraj V; Malik F; Zaidi A
    J Infect Dev Ctries; 2008 Aug; 2(4):289-94. PubMed ID: 19741291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial resistance in Salmonella enterica serovar typhi and paratyphi in South Asia-current status, issues and prospects.
    Akhtar S; Sarker MR; Jabeen K; Sattar A; Qamar A; Fasih N
    Crit Rev Microbiol; 2015; 41(4):536-45. PubMed ID: 24645636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
    Slinger R; Desjardins M; McCarthy AE; Ramotar K; Jessamine P; Guibord C; Toye B
    BMC Infect Dis; 2004 Sep; 4():36. PubMed ID: 15380025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Sensitivity to antibiotics of Salmonella typhi and paratyphi strains isolated in Algeria 1979-1984].
    Zoukh K
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):608-10. PubMed ID: 3534753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a real-time PCR assay for detection of gyrA mutations associated with reduced susceptibility to ciprofloxacin in Salmonella enterica serovar typhi and paratyphi A.
    Morita M; Ito K; Hirose K; Takahashi H; Shimuta K; Terajima J; Ohnishi M; Harada M; Matsuzaki M; Watanabe H; Izumiya H
    Microbiol Immunol; 2006; 50(9):707-11. PubMed ID: 16985292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro susceptibility of typhoidal Salmonellae against newer antimicrobial agents: a search for alternate treatment options.
    Qaiser S; Irfan S; Khan E; Ahsan T; Zafar A
    J Pak Med Assoc; 2011 May; 61(5):462-5. PubMed ID: 22204180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in antimicrobial susceptibility of Salmonella Typhi from North India (2001-2012).
    Singhal L; Gupta PK; Kale P; Gautam V; Ray P
    Indian J Med Microbiol; 2014; 32(2):149-52. PubMed ID: 24713900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of ofloxacin against 210 clinical isolates of typhoid salmonellae.
    Hannan A
    Infection; 1986; 14 Suppl 4():S243-4. PubMed ID: 3102385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.